Pancreatic Cancer Action Network Awards More Than $5.1 Million in Research Grant Funding
The Pancreatic Cancer Action Network is pleased to award more than $5.1 million in research grant funding in 2014. Overall, the organization has awarded nearly $23 million through 110 research grants to bright and dedicated scientists and clinicians throughout the country.
We invite you to read the profiles of each of our distinguished grant recipients listed below, as well as our press release about the Pancreatic Cancer Action Network 2014 grants program.
2014 Research Grants
![]() Michael Barrett, PhD Mayo Clinic Cancer Center, Scottsdale Genomic Drivers of Therapeutic Responses in Metastatic Disease |
![]() Dafna Bar-Sagi, PhD New York University School of Medicine PDA Development: Heads or Tails? |
![]() David Boothman, PhD University of Texas Southwestern Medical Center Exploiting an NQO1 ‘kiss of death’ for pancreatic cancer therapy |
![]() David DeNardo, PhD Washington University in St. Louis Origins and Impact of Macrophages in Pancreatic Cancer |
![]() Gina DeNicola, PhD Weill Cornell Medical College Therapeutic Targeting of NRF2-regulated Metabolism in Pancreatic Cancer |
![]() Giulio Draetta, MD, PhD, MD Anderson Cancer Center Co-Principal Investigator: Lewis Cantley, PhD, Weill Cornell Medical College Developing a Novel Oxidative Phosphorylation Inhibitor in Pancreatic Cancer |
![]() Barbara Grüner, PhD Stanford University Multiplexed In Vivo Drug Screening: Inhibitors of Metastatic Seeding |
![]() Eugene Koay, MD, PhD MD Anderson Cancer Center Changes in Mass Transport as a Biomarker of Response in Pancreatic Cancer |
![]() Dung Le, MD, Johns Hopkins University Co-Principal Investigator: Todd Crocenzi, MD, Providence Portland Medical Center GVAX + CRS-207 Heterologous Prime Boost Vaccination with PD-1 Blockade |
![]() Anirban Maitra, MBBS MD Anderson Cancer Center Macrophage Function in Pancreatic Cancer-associated Diabetes |
![]() Florencia McAllister, MD MD Anderson Cancer Center Targeting IL-17 Signaling Axis in Pancreatic Ductal Adenocarcinoma |
![]() George Miller, MD New York University School of Medicine Regulation of Pancreatic Tumorigenesis by Necroptosis |
![]() Kenneth Scott, PhD Baylor College of Medicine Functionalizing Metabolic Pathway Driver Aberrations in Pancreatic Cancer |
![]() Diane Simeone, MD University of Michigan Mesenchymal Stem Cells in Pancreatic Cancer Biology and Therapeutic Development |
![]() David Ting, MD Massachusetts General Hospital Circulating Tumor Cells to Assess Pancreatic Cancer Disease Status |
![]() Kathryn Wellen, PhD University of Pennsylvania Understanding Metabolic Control of the Pancreatic Cancer Epigenome |